Basit öğe kaydını göster

dc.contributor.authorYegen, Gizem
dc.contributor.authorCevher, Erdal
dc.contributor.authorAksu, Buket
dc.date.accessioned2021-12-10T10:19:49Z
dc.date.available2021-12-10T10:19:49Z
dc.date.issued2021
dc.identifier.citationYegen G., Aksu B., Cevher E., "Design of an orally disintegrating tablet formulation containing metoprolol tartrate in the context of quality by design approach", JOURNAL OF RESEARCH IN PHARMACY, cilt.25, sa.5, ss.728-737, 2021
dc.identifier.othervv_1032021
dc.identifier.otherav_391a1b52-a43a-4c82-afa0-d1d133821de6
dc.identifier.urihttp://hdl.handle.net/20.500.12627/169685
dc.identifier.urihttps://doi.org/10.29228/jrp.63
dc.description.abstractOrally Disintegrating Tablets (ODTs) are solid dosage forms that rapidly disintegrate or dissolve to release the drug upon contact with saliva in the mouth. As these tablets require special attention during formulation design, it is necessary to use advanced control and formulation design techniques to increase the quality. Quality by Design (QbD) was defined as an approach including better scientific understanding of critical process and product attributes, designing controls and tests based on scientific understanding limits during development stage and used to work in an environment for continuous improvement of information obtained during the product lifecycle. The aim of the study was to develop an ODT formulation containing Metoprolol tartrate with appropriate features via QbD approach with the help of artificial intelligence programs to enlight the multivariate relations between critical parameters and quality attributes of on final product and to obtain an optimum formulation. Physical and chemical tests were conducted on tablets prepared by direct compression according to the designated formulation and process variables. Then, experimental data was evaluated with modeling programs use artificial intelligence technique, FormRules V3.32 to understand the relationship between independent input variables and the critical quality attributes; later with INForm V5.1 for optimization. The optimized formula was prepared and according to test results tablets shows compliance with the pharmacopoeia limits. The adoption of QbD approach and usage of artificial intelligence programs has increased the efficiency of the formulation development process with better understanding of the product and process.
dc.language.isoeng
dc.subjectTemel Bilimler
dc.subjectPharmacology
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectPharmacology (medical)
dc.subjectPharmacy
dc.subjectDrug Guides
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectEczacılık
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleDesign of an orally disintegrating tablet formulation containing metoprolol tartrate in the context of quality by design approach
dc.typeMakale
dc.relation.journalJOURNAL OF RESEARCH IN PHARMACY
dc.contributor.departmentİstanbul Teknik Üniversitesi , ,
dc.identifier.volume25
dc.identifier.issue5
dc.identifier.startpage728
dc.identifier.endpage737
dc.contributor.firstauthorID2742503


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster